3.1 PD and insulin resistance Insulin resistance (IR) is usually considered a systemic response or reduced sensitivity to insulin effects
"Bioavailability study of an innovative orobuccal formulation of glutathione." Oxid Med Cell Longev
doi: 10.1023/A:1024433100257
ScienceDirect , Gofron, Krzysztof Ksawery, Andrzej Wasilewski, and Sylwia Magorzewicz
Increased competition (tirzepatide, survodutide, orforglipron), political pressure, and the growth of the compounding market are all pushing toward lower prices
Several of these drugs (exenatide (Byetta and Bydureon), liraglutide (Victoza for diabetes, Saxenda for obesity) albiglutide (Tanzeum), dulaglutide (Trulicity), and lixisenatide (Lyxumia in Europe, Adlyxin in the United States) have been around for at least ten years